JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerk, P. M.
Right arrow Articles by McNamara, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerk, P. M.
Right arrow Articles by McNamara, P. J.

Vol. 296, Issue 1, 175-180, January 2001

Interactions between Cimetidine, Nitrofurantoin, and Probenecid Active Transport into Rat Milk

Phillip M. Gerk, Cheah Y. Oo, Earl W. Paxton, Jeffrey A. Moscow and Patrick J. McNamara

University of Kentucky College of Pharmacy, Division of Pharmaceutical Sciences, Lexington, Kentucky (P.M.G., E.W.P., P.J.M.); Hoffman LaRoche, Inc., Department of Clinical Pharmacology, Nutley, New Jersey (C.Y.O.); and University of Kentucky College of Medicine, Department of Pediatrics, Lexington, Kentucky (J.A.M.)

The purpose of these studies was to further elucidate the active mammary epithelial transport processes for the organic cation cimetidine and the organic anion nitrofurantoin and to determine which of the identified rat organic anion (rOATs) and organic cation (rOCTs) transporters may be responsible for transport of these drugs into milk. Milk-to-serum ratios (M/S) were predicted in vitro for nitrofurantoin, p-aminohippurate (PAH), and probenecid, and were compared with the observed M/S values. Groups of six lactating female rats received intravenous infusions of cimetidine, nitrofurantoin, PAH, or probenecid alone and with another agent. Steady-state milk and serum concentrations were measured by high performance liquid chromatography. Reverse transcriptase-polymerase chain reaction was performed to detect rOATs and rOCTs in livers, kidneys, and mammary glands of lactating rats. Nitrofurantoin and probenecid were actively transported into rat milk with an M/S 100- and 4.7-fold greater than predicted, respectively, but predicted and observed M/S values for PAH were similar. The cimetidine infusion did not alter nitrofurantoin M/S. Nitrofurantoin significantly decreased M/S of cimetidine (26.6 ± 4.9 versus 17.7 ± 5.6). Probenecid did not alter the M/S of nitrofurantoin, or PAH, but increased the M/S of cimetidine from 15.5 ± 3.6 to 21.5 ± 7.7. Of the six transporter genes, evidence of expression in lactating rat mammary tissue was found for only rOCT1 and rOCT3. The results suggest different secretory transport systems for cimetidine, nitrofurantoin, and probenecid, but that passive diffusion governs PAH passage into milk. The products of rOCT1 and rOCT3 might transport these drugs into milk.


0022-3565/01/2961-0175$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
L. Wang, M. Leggas, M. Goswami, P. E. Empey, and P. J. McNamara
N-(4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine Carboxamide (GF120918) As a Chemical ATP-Binding Cassette Transporter Family G Member 2 (Abcg2) Knockout Model to Study Nitrofurantoin Transfer into Milk
Drug Metab. Dispos., December 1, 2008; 36(12): 2591 - 2596.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Vore and M. Leggas
Progesterone Acts via Progesterone Receptors A and B to Regulate Breast Cancer Resistance Protein Expression
Mol. Pharmacol., March 1, 2008; 73(3): 613 - 615.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Kwok, A. Yamauchi, R. Rajesan, L. Chan, U. Dhillon, W. Gao, H. Xu, B. Wang, S. Takahashi, J. Semple, et al.
Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R793 - R802.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Merino, J. W. Jonker, E. Wagenaar, A. E. van Herwaarden, and A. H. Schinkel
The Breast Cancer Resistance Protein (BCRP/ABCG2) Affects Pharmacokinetics, Hepatobiliary Excretion, and Milk Secretion of the Antibiotic Nitrofurantoin
Mol. Pharmacol., May 1, 2005; 67(5): 1758 - 1764.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. M. Gerk, J. A. Moscow, and P. J. McNamara
BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION
Drug Metab. Dispos., June 1, 2003; 31(6): 691 - 693.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Alcorn and P. J. McNamara
Acyclovir, Ganciclovir, and Zidovudine Transfer into Rat Milk
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1831 - 1836.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.